1. Methodologic limitations of prescription opioid safety research and recommendations for improving the evidence base;Ranapurwala;Pharmacoepidemiol Drug Saf,2018
2. US Centers for Disease Control and Prevention Guideline for opioid prescribing for patients with chronic, non-cancer pain in prim care settings https://www.cdc.gov/drugoverdose/prescribing/guideline.html
3. The Centers for Disease Control and Prevention opioid guidelines: potential for unintended consequences and will they be abused?;Pergolizzi;J Clin Pharm Ther,2016
4. US Food and Drug Administrations Opioid Policy Steering Committee Prescribing intervention-exploring a strategy for implementation Part 15 public hearing https://www.fda.gov/downloads/NewsEvents/MeetingsConferencesWorkshops/UCM596737.pdf
5. Speech by Scott Gottlieb, M.D., Commissioner of US Food and Drug Administration, at the National Rx Drug Abuse and Heroin Summit https://www.fda.gov/newsevents/speeches/ucm603651.htm